Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders (GAF)

9 mars 2016 uppdaterad av: Moritz Petzold, Charite University, Berlin, Germany

Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders: Motivational Determinants of Adherence, Effect on Cognitive Determinants of Physical Activity, Physical Activity, Sitting Time and Clinical Symptoms

The purpose of this study is to determine if a manualised intervention to promote physical activity (MoVo-LISA) is effective to help psychiatric outpatients to increase their level of everyday physical activity.

Studieöversikt

Detaljerad beskrivning

The Intervention program MoVo-LISA is a psychological intervention that should help participants to increase their level of physical activity for a healthy lifestyle.It contains three sessions (2 group,1 one on one) in the course of two weeks. The intervention focuses on planning and barrier management.

Participants develop activity ideas, goals and plans that enable them to integrate physical activity in their everyday routine and how to shield their motivation against barriers and difficulties.The intervention has proven to be effective with patients with pain disorders in rehabilitation.

This study examines if the intervention if effective for psychiatric outpatients as well. The intervention is compared to an active control group that receives a similar program that is focusing on a healthy diet.

Participants are recruited in the outpatient departements of three hospitals in Berlin and Brandenburg (Charité Universitätsmedizin Berlin - Departement of Psychiatry and Psychotherapy; St. Hewdig Hospital Berlin - Departement of Psychiatry; Oberhavel Hospital Brandenburg, Departement of Psychiatry) and at local psychiatrists in Berlin. Individuals are recruited by posters and flyers in the waiting areas areas or by information of their doctor. Patients can contact the researcher and are, after checked for eligibility, invited to an information event, where they get detailed information on the program and the study. After the information event, participants give written informed consent.

The intervention takes place in the outpatient departements of the three hospitals.

Clinical information about diagnoses, medication and functioning is obtained by their doctors by mail after the patients released them from confidentiality.

The study is an explorative approach to test if the program is suited for psychiatric patients. A sample size of 50 participants that complete the program is planned.

All data is collected pseudonymised to protect the identity of the patients.

Studietyp

Interventionell

Inskrivning (Faktisk)

86

Fas

  • Fas 2

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Berlin, Tyskland, 10117
        • Charité Universitätsmedizin Berlin - Departement of Psychiatry

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Over 18 years of Age
  • Patients in one of the psychiatric outpatients or at an local psychiatrist in Berlin
  • Mental illness (ICD-10: F1-F4)
  • No contraindications for physical activity
  • Able to understand german language

Exclusion Criteria:

  • Contraindications to physical activity
  • Acute suicidality

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Activity Intervention
The activity intervention is MoVo-LISA (Göhner & Fuchs, 2007). A psychological program with two group sessions of 90 minutes and one one-on-one session of about 15 minutes. The patients develop aims for their health, ideas, how to reach these aims through physical activity and make detailed plans, how to implement activity in their everyday routine. Difficulties and barriers are discussed.
Aktiv komparator: Healthy Diet Intervention
The healthy diet intervention is a modification of MoVo-LISA. A psychological program with two group sessions of 90 minutes and one one-on-one session of about 15 minutes. The patients develop aims for their health, ideas, how to reach these aims through a healthy diet and make detailed plans, how to implement a healthy diet in their everyday routine. Difficulties and barriers are discussed.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in physical activity - objective
Tidsram: From baseline (T1) to 3 month after the intervention (T3)
Physical activity is objectively measured using accelerometry (ActiGraph GT1M)
From baseline (T1) to 3 month after the intervention (T3)
Change in physical activity - subjective
Tidsram: From baseline (T1) to 3 month after the intervention (T3)
Physical activity is subjectively measured with the International Physical Activity Questionaire (IPAQ)
From baseline (T1) to 3 month after the intervention (T3)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in self-efficacy
Tidsram: From baseline (T1) to 1 week after the intervention (T2)
Self-efficacy is measured using two likert scaled items
From baseline (T1) to 1 week after the intervention (T2)
Change in intention for physical activity
Tidsram: From baseline (T1) to 1 week after the intervention (T2)
Intention for physical activity is measured using two likert scaled items
From baseline (T1) to 1 week after the intervention (T2)
Change in self concordance of the motivation for physical activity
Tidsram: From baseline (T1) to 1 week after the intervention (T2)
Self concordance of the motivation for physical activity is measured using the "Sport- und bewegungsbezogene Selbstkonkordanz Skala", which consists of 12 likert scaled items
From baseline (T1) to 1 week after the intervention (T2)
Change in outcome expectancies for physical activity
Tidsram: From baseline (T1) to 1 week after the intervention (T2)
Outcome expectancies for physical activity are measured using 6 likert scaled items
From baseline (T1) to 1 week after the intervention (T2)
Change in planning for physical activity
Tidsram: From baseline (T1) to 1 week after the intervention (T2)
Planning for physical activity is measured using 4 likert scaled items
From baseline (T1) to 1 week after the intervention (T2)
Change in barrier planning for physical activity
Tidsram: From baseline (T1) to 1 week after the intervention (T2)
Barrier planning for physical activity is measured using 4 likert scaled items
From baseline (T1) to 1 week after the intervention (T2)
Change in psychopathological symptoms
Tidsram: From baseline (T1) to 3 month after the intervention (T3)
Psychopathological symptoms are measured by the Symptom Checklist 27 (SCL-27)
From baseline (T1) to 3 month after the intervention (T3)
Change in health-related quality of life
Tidsram: From baseline (T1) to 3 month after the intervention (T3)
Health-related quality of life is measured using the Sort-Form Health Questionnaire 12 (SF-12)
From baseline (T1) to 3 month after the intervention (T3)
Change in dietary behavior
Tidsram: From baseline (T1) to 3 month after the intervention (T3)
Dietary behavior is measured using the Food Frequency Questionnaire (FEL)
From baseline (T1) to 3 month after the intervention (T3)
Change in consumption of portions of fruit and vegetable per day
Tidsram: From baseline (T1) to 3 month after the intervention (T3)
Consumption of fruit and vegetable is measured using two items asking for the number of portions of fruit and vegetable that are consumed on a regular day (a portion is defined as a hand full). Consumption of fruit and vegetable is then added to check if the WHO recommendation of "5 a day" is met
From baseline (T1) to 3 month after the intervention (T3)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Studierektor: Andreas Ströhle, Prof., Charité Universitätsmedizin Berlin - Departement of Psychiatry and Psychotherapy
  • Huvudutredare: Moritz B Petzold, Dipl.Psych., Charité Universitätsmedizin Berlin - Departement of Psychiatry and Psychotherapy

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 april 2014

Primärt slutförande (Faktisk)

1 mars 2016

Avslutad studie (Faktisk)

1 mars 2016

Studieregistreringsdatum

Först inskickad

2 oktober 2015

Först inskickad som uppfyllde QC-kriterierna

5 oktober 2015

Första postat (Uppskatta)

7 oktober 2015

Uppdateringar av studier

Senaste uppdatering publicerad (Uppskatta)

10 mars 2016

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

9 mars 2016

Senast verifierad

1 mars 2016

Mer information

Termer relaterade till denna studie

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera